Israeli Hospitals Evolve into High-Tech Data Hubs
Translated & summarized from Ynet by baba
Israeli hospitals are increasingly leveraging medical data as a valuable asset for research, AI development, and innovation. Key figures like Prof. Dani Eitan and Dr. Michal Makel emphasize the importance of patient trust and the need for national standards in data utilization. These issues will be central to the upcoming Rambam Tomorrow conference.
The story in 5 lines · by baba
- Israeli hospitals are becoming data hubs, using patient information for research and AI development.
- Prof. Dani Eitan highlights AI's potential to predict medical deterioration using vast patient data.
- Dr. Michal Makel stresses that patient data is a hospital's most valuable asset, surpassing equipment.
- Ensuring patient privacy and trust is paramount for realizing the economic and medical benefits of data.
- There is a call for national standards to govern the use and sharing of medical data in Israel.
Israeli hospitals are transforming into significant centers for data and innovation, leveraging vast amounts of medical information to drive advancements in research, drug development, and artificial intelligence. Prof.
He points out Israel's unique advantage in this field due to its public healthcare system and early adoption of electronic medical records. The continuity of care between hospitals and health maintenance organizations provides a comprehensive view of patients. Dr. Michal Makel, CEO of Rambam, emphasizes that this medical data, accumulated over years from lab results, imaging, diagnoses, and treatments, is now the most valuable asset in a large hospital, surpassing expensive equipment.
This data, when combined with infrastructure and clinical knowledge, can accelerate development, improve treatment decisions, and foster the creation of billion-dollar tech companies. Consequently, hospitals are becoming data laboratories and innovation platforms where medical professionals and data scientists collaborate. Prof. Eitan notes that data has significant financial value, citing an instance where IBM paid $5 billion to a US health organization for patient data.
However, the effective use of this data requires clinical context and expert interpretation. Rambam, in collaboration with the Technion, has established TERA to bridge the gap between laboratory research and patient care, facilitating digital coordination for complex cases. The hospital also benefits from partnerships with leading tech companies in the Haifa area.
Hagar Trau, Head of Rambam's Digital and Information Technologies Division, stresses the critical importance of data security and privacy, likening the handling of medical information to military-grade confidentiality. Measures include using anonymized data for research, obtaining patient consent for intervention studies, and operating within secure hospital networks. Rambam has formed a special AI committee comprising management, clinicians, ethicists, legal experts, and privacy officers to rigorously evaluate AI applications for medical validation, safety, confidentiality, and ethics.
Prof. Eitan asserts that while patient data belongs to the patient, hospitals act as custodians, investing in its collection and quality. He advocates for a "sacred trust" approach to its use and calls for national standards for data utilization and sharing, noting the absence of a unified national framework. Dr. Makel concludes that realizing the economic potential of medical data hinges on building a strong foundation of patient trust, without which the financial value could be lost, and more importantly, public trust in the healthcare system could be damaged.